NasdaqCM:CPRXBiotechs
Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Strong Recent Share Price Gains
If you are wondering whether Catalyst Pharmaceuticals is priced fairly or still offers value, it helps to start by looking at what the recent share price and fundamentals are actually telling you.
The stock last closed at US$29.27, with returns of 12.3% over the past week, 25.1% over the past month, 26.4% year to date, 23.9% over the past year, 72.8% over three years and a very large gain over five years.
Recent price moves have been in the spotlight as investors react to ongoing...